Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
In this study, we developed a simple, sensitive, accurate, and rapid analytical method for detecting therapeutic monoclonal antibodies in plasma samples using immunoaffinity purification e HT-RPLC with fluorescence detection. We successfully applied both methods to the bioanalyses of plasma samples obtained from cancer and RA patients who were administered each drug. The methods described here are applicable for planning optimal therapeutic programs, and also for the evaluation of biological equivalencies in the development of biosimilars.
|